InterCure Stock

InterCure P/TBV

Price to Tangible Book Value (P/TBV) of InterCure (INCR.TA) as of Aug 17, 2026.

P/TBV

0.00

Last updated:

Price to Tangible Book Value (P/TBV) of InterCure is 2026 0.00 . Price to Tangible Book Value (P/TBV) of InterCure was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) InterCure since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s InterCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — InterCure

All Key Metrics — InterCure